Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial

•Toddlers in a randomized maternal Tdap immunization trial received a DTaP-HepB-IPV/Hib booster.•Response to pertussis and to other antigens were similarly high in toddlers from vaccinated and unvaccinated mothers.•Antibody concentrations for two pertussis antigens and diphtheria were lower in toddl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2021-03, Vol.39 (11), p.1598-1608
Hauptverfasser: Martinón-Torres, Federico, Halperin, Scott A., Nolan, Terry, Tapiéro, Bruce, Perrett, Kirsten P., de la Cueva, Ignacio Salamanca, García-Sicilia, José, Stranak, Zbynek, Vanderkooi, Otto G., Kosina, Pavel, Rumlarova, Sarka, Virta, Miia, Arribas, Jose M. Merino, Miranda-Valdivieso, Mariano, Novas, Begoña Arias, Bozensky, Jan, Ortega, María José Cilleruelo, Amador, Jose Tomas Ramos, Baca, Manuel, Palomino, Esperanza Escribano, Zuccotti, Gian Vincenzo, Janota, Jan, Marchisio, Paola Giovanna, Kostanyan, Lusine, Meyer, Nadia, Ceregido, Maria Angeles, Cheuvart, Brigitte, Kuriyakose, Sherine O., Mesaros, Narcisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Toddlers in a randomized maternal Tdap immunization trial received a DTaP-HepB-IPV/Hib booster.•Response to pertussis and to other antigens were similarly high in toddlers from vaccinated and unvaccinated mothers.•Antibody concentrations for two pertussis antigens and diphtheria were lower in toddlers from vaccinated mothers.•The clinical significance of this immune interference needs long-term monitoring. Transplacentally transferred antibodies induced by maternal pertussis vaccination interfere with infant immune responses to pertussis primary vaccination. We evaluated whether this interference remains in toddlers after booster vaccination. In a prior phase IV, observer-blind, placebo-controlled, randomized study (NCT02377349), pregnant women in Australia, Canada and Europe received intramuscular tetanus-reduced-antigen-content diphtheria-three-component acellular pertussis vaccine (Tdap group) or placebo (control group) at 270/7–366/7 weeks’ gestation, with crossover immunization postpartum. Their infants were primed (study NCT02422264) and boosted (at 11–18 months; current study NCT02853929) with diphtheria-tetanus-three-component acellular pertussis-hepatitis B virus-inactivated poliovirus/Haemophilus influenzae type b vaccine (DTaP-HepB-IPV/Hib) and 13-valent pneumococcal conjugate vaccine. Immunogenicity before and after booster vaccination, and reactogenicity and safety of the booster were evaluated descriptively. 263 (Tdap group) and 277 (control group) toddlers received a DTaP-HepB-IPV/Hib booster. Pre-booster vaccination, observed geometric mean concentrations (GMCs) for the three pertussis antigens and diphtheria were 1.4–1.5-fold higher in controls than in the Tdap group. No differences were observed for the other DTaP-HepB-IPV/Hib antigens. One month post-booster vaccination, booster response rates for pertussis antigens were ≥ 92.1% and seroprotection rates for the other DTaP-HepB-IPV/Hib antigens were ≥ 99.2% in both groups (primary objective). Higher post-booster GMCs were observed in controls versus the Tdap group for anti-filamentous hemagglutinin (1.2-fold), anti-pertussis toxoid (1.5-fold) and anti-diphtheria (1.4-fold). GMCs for the other DTaP-HepB-IPV/Hib antigens were similar between groups. Serious adverse events were reported for three toddlers (controls, not vaccination-related). One death occurred pre-booster (Tdap group, not vaccination-related). As a consequence of interference of maternal pertussis antibodies with infant imm
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2021.02.001